McKesson Corporation?s Strong Dividend Growth Signals Confidence and Market Resilience In a decisive move that speaks volumes about its financial health and strategic outlook, McKesson Corporation (NYSE: MCK) has announced a 15% increase in its quarterly dividend, raising the payout from $0.62 to $0.71 per share. The Board of Directors declared this new dividend, which is set to be distributed on October 1, 2024, to shareholders of record as of September 2, 2024. This increase not only marks McKesson?s eighth consecutive annual dividend boost but also reflects robust business fundamentals and a strong balance sheet, underpinned by healthy free cash flow generation.
Key Financial Highlights - Quarterly Dividend Increase: The dividend per share rises from $0.62 to $0.71, representing a 15% increase. - Record Date: Shareholders will need to be on record by September 2, 2024, to receive the new dividend on October 1. - Consistency in Growth: This is the eighth consecutive annual dividend increase, indicating a steady commitment to returning value to shareholders.
|
In a recent press release, the McKesson Corporation, a prominent healthcare services leader, announced the declaration of a regular dividend of 62 cents per share of common stock. The dividend is scheduled to be payable on April 1, 2024, to stockholders of record on March 1, 2024. This development comes as McKesson Corporation continues to showcase remarkable growth, with its stock surging by 10.7% over the past three months and an astounding 370.98% over the past year, reaching a new 52-week high.
The McKesson Corporation, headquartered in Irving, Texas, is positioned as a diversified healthcare services leader, committed to enhancing health outcomes for patients worldwide. Through collaborative efforts with biopharmaceutical firms, care providers, pharmacies, and manufacturers, the company aims to revolutionize the healthcare landscape.
|